Tag: Pharmaceuticals & Biotech

Posted on by — Leave a comment

Hypertrophic Cardiomyopathy Market Expected to Experience Major Growth by 2034, According to DelveInsight | Edgewise Therapeutics, Inc., Lexicon Pharmaceuticals, Shandong Suncadia Medicine, Ji Xing

The Key Hypertrophic Cardiomyopathy Companies in the market inlcude – Edgewise Therapeutics, Inc., Lexicon Pharmaceuticals, Shandong Suncadia Medicine, Ji Xing Pharmaceuticals, Rocket Pharmaceuticals, Bristol-Myers Squibb, Novartis, Gilead Sciences, Cytokinetics, Imbria Pharmaceuticals, MyoKardia, Inc., Cytokinetics, Tenaya Therapeutics, Novartis, and others.   DelveInsight’s “Hypertrophic Cardiomyopathy Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of […]

Posted on by — Leave a comment

Age-related Macular Degeneration (AMD) Drugs Market to Hit $17.37 Billion by 2029

The North American region is expected to account for the fastest-growing region of the AMD drugs market during the forecast period. This region has a diverse pool of patients who adopt a wide range of therapeutics. Companies within the AMD drugs market are researching newer drug modalities such as gene therapy, hydrogels, and inhibitor drugs […]

Posted on by — Leave a comment

Interstitial Lung Disease Treatment Market Size in the 7MM is expected to grow by 2034, estimates DelveInsight

Interstitial Lung Disease Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Interstitial Lung Disease Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.   DelveInsight’s “Interstitial Lung Disease […]

Posted on by — Leave a comment

Multiple Sclerosis Pipeline Dynamics 2024: FDA Approvals, Therapeutic Advances, MOA, ROA by DelveInsight | Biogen, Immune Response BioPharma, Celgene, Novartis, Sanofi, Actelion, Bayer, Acorda

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Multiple Sclerosis pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple Sclerosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   The Multiple Sclerosis Pipeline report embraces in-depth commercial and clinical assessment of the […]

Posted on by — Leave a comment

Pompe Disease Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Market Dynamics, MOA, ROA by DelveInsight | M6P Therapeutics, Entrada Therapeutics, Maze Therapeutics, Astellas

Las Vega (Nevada), United States //— As per DelveInsight’s assessment, globally, Pompe Disease pipeline constitutes 15+ key companies continuously working towards developing 20+ Pompe Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   “Pompe Disease Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into […]

Posted on by — Leave a comment

Severe Hypertriglyceridemia Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Ionis Pharma, 89bio, Inc., Arrowhead Pharma, Hightide Therapeutics, AstraZeneca, Kowa

The Key Severe Hypertriglyceridemia Companies in the market include – Amarin Corporation, Ionis Pharmaceuticals, 89bio, Inc., Arrowhead Pharmaceuticals, Inc., Hightide Therapeutics, AstraZeneca, Kowa Research Institute, Inc., Regeneron Pharmaceuticals, Mochida Pharmaceutical, NeuroBo Pharma, Arisaph Pharma, Acasti Pharma Inc., and others.   DelveInsight’s “Severe Hypertriglyceridemia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of […]

Posted on by — Leave a comment

Near infrared imaging Market/ worth $1.6 billion by 2028, with a CAGR of 10.2%

Near infrared imaging market forecasted to transform from $1.0 billion in 2023 to $1.6 billion by 2028, driven by a CAGR of 10.2%. Key drivers of this market include an increasing number of surgical procedures due to rising incidences of chronic diseases such as cancer and cardiovascular conditions, and a growing focus on precision medicine. […]

Posted on by — Leave a comment

Knee Osteoarthritis Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Paradigm Biopharma, Organogenesis, BioSenic (Bone Therapeutics), Sorrento Therapeutics, Inc

The Key Knee Osteoarthritis Companies in the market include – Taiwan Liposome Company, Centrexion Therapeutics, Biosplice Therapeutic, Noven Pharmaceuticals, Kolon TissueGene, Paradigm Biopharmaceuticals, Organogenesis, BioSenic (Bone Therapeutics), Sorrento Therapeutics, Inc., ICM Biotech Australia, Grünenthal GmbH, Akan Biosciences, LLC, GlaxoSmithKline, and others.   DelveInsight’s “Knee Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth […]

Posted on by — Leave a comment

Fanconi Anemia Market Expected to Experience Major Growth by 2034, According to DelveInsight | Novartis, Foresee Pharma, Rocket Pharma, Jasper Therapeutics

The Key Fanconi Anemia Companies in the market include – Rocket Pharma, Foresee Pharmaceuticals, Jasper Therapeutics, Novartis, and others.   DelveInsight’s “Fanconi Anemia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Fanconi Anemia, historical and forecasted epidemiology as well as the Fanconi Anemia market trends in the United States, EU4 […]

Posted on by — Leave a comment

Degenerative Disc Disease Treatment Market Size in the 7MM was ~USD 3,600 Million in 2023, estimated DelveInsight

Degenerative Disc Disease Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Degenerative Disc Disease Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.   DelveInsight’s “Degenerative Disc Disease Market […]